Your session is about to expire
← Back to Search
MyPEEPS Mobile for HIV Prevention
Study Summary
This trial is testing a new way to prevent HIV infection in young transgender men, who are at high risk for the disease. If successful, this could be a life-saving intervention for this vulnerable population.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 15 and 19 years old.I've had unprotected sex in the past year.I identify as a transgender man or on the transmasculine spectrum.I was assigned female at birth.You have a smartphone.
- Group 1: Immediate Intervention
- Group 2: Delayed Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are any new participants being enrolled in this trial currently?
"Affirmative. Data on clinicaltrials.gov affirms that this medical trial initiated recruitment efforts on June 1st 2023 and was most recently updated 15 days ago. Currently, 80 patients need to be sourced from 3 distinct locations."
Can I register for this medical experiment?
"This HIV clinical trial is currently open to applicants aged between 15-19. Over the course of this study, 80 participants will be accepted."
How many individuals have enrolled for this clinical investigation?
"Affirmative. Per the clinicaltrials.gov website, this trial which launched on June 1st 2023 is presently recruiting for 80 individuals over three medical centres. An update was last made to the page on June 15th 2022."
Does the eligibility criteria for this medical trial encompass individuals of advanced age?
"This research is enrolling subjects aged 15 and above, but below 19 years old."
Share this study with friends
Copy Link
Messenger